The abnormal mechanoresponses of H3K9me3 and HDAC in vECs after ALS exposure can be reversed by ITSA-1 treatment, which could be a strategy to prevent vascular graft failure. Here, HDAC9 is linked to amyotrophic lateral sclerosis.